Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Vaccines
Vaccines
Page 23 of 31
Health
U.S. plan to vaccinate most Americans by summer depends on AstraZeneca and J&J
By
Riley Griffin
and
Bloomberg
December 9, 2020
Health
Only 10% of people in poor countries will get a coronavirus vaccine next year
By
David Z. Morris
December 9, 2020
Health
Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
By
Katherine Dunn
December 8, 2020
Health
The science behind the leading COVID vaccines will lead to faster manufacturing
By
Sy Mukherjee
December 5, 2020
International
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
By
Naomi Xu Elegant
November 30, 2020
Politics
Biden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
By
The Associated Press
and
Lisa Mascaro
November 28, 2020
Finance
Bet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
By
Anne Sraders
November 28, 2020
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By
Suzi Ring
,
James Paton
and
Bloomberg
November 27, 2020
Health
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By
Angelica LaVito
,
John Lauerman
and
Bloomberg
November 25, 2020
Health
AstraZeneca says its Covid-19 vaccine is up to 90% effective
By
Jeremy Kahn
November 23, 2020
Newsletters
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
By
Bernhard Warner
November 12, 2020
Health
U.K. to use A.I. to spot dangerous side effects in the millions of COVID-19 vaccinations it will deliver
By
Jeremy Kahn
November 5, 2020
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By
Suzi Ring
,
James Paton
and
Bloomberg
November 5, 2020
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
November 4, 2020
Conferences
CEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
By
Naomi Xu Elegant
October 27, 2020
Most Popular
Success
MacKenzie Scott gifts $80 million to Howard University, marking one of the school’s largest donations in its 158-year...
By
Sydney Lake
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use...
By
Preston Fore
Success
Chanel’s CEO went to Microsoft HQ and asked ChatGPT to show her a picture of her company’s leadership. They were all...
By
Sasha Rogelberg